Second-line salvage regimens
| Regimen . | thal/dex (n = 139), n (%) . | len/dex (n = 97), n (%) . | P . |
|---|---|---|---|
| Transplantation | 14 (10.1) | 18 (18.6) | .061 |
| Bortezomib-based regimen | 21 (15.1) | 28 (28.9) | .014 |
| Lenalidomide-based regimen | 34 (24.5) | 22 (22.7) | .752 |
| Lenalidomide-bortezomib based regimen | 0 (0) | 4 (4.1) | .028 |
| Thalidomide-based regimen | 23 (16.6) | 10 (10.3) | .174 |
| Others | 47 (33.8) | 15 (15.5) | .002 |
| Regimen . | thal/dex (n = 139), n (%) . | len/dex (n = 97), n (%) . | P . |
|---|---|---|---|
| Transplantation | 14 (10.1) | 18 (18.6) | .061 |
| Bortezomib-based regimen | 21 (15.1) | 28 (28.9) | .014 |
| Lenalidomide-based regimen | 34 (24.5) | 22 (22.7) | .752 |
| Lenalidomide-bortezomib based regimen | 0 (0) | 4 (4.1) | .028 |
| Thalidomide-based regimen | 23 (16.6) | 10 (10.3) | .174 |
| Others | 47 (33.8) | 15 (15.5) | .002 |